CSF cortisol in Alzheimer's disease and mild cognitive impairment.

Détails

ID Serval
serval:BIB_B191279EFFFE
Type
Article: article d'un périodique ou d'un magazine.
Collection
Publications
Titre
CSF cortisol in Alzheimer's disease and mild cognitive impairment.
Périodique
Neurobiology of Aging
Auteur⸱e⸱s
Popp J., Schaper K., Kölsch H., Cvetanovska G., Rommel F., Klingmüller D., Dodel R., Wüllner U., Jessen F.
ISSN
1558-1497 (Electronic)
ISSN-L
0197-4580
Statut éditorial
Publié
Date de publication
2009
Peer-reviewed
Oui
Volume
30
Numéro
3
Pages
498-500
Langue
anglais
Notes
Publication types: Comparative Study ; Journal Article ; Research Support, Non-U.S. Gov'tPublication Status: ppublish
Résumé
Hypercortisolaemia occurs in Alzheimer's disease (AD) and may be involved in the AD related neurodegenerative process. In order to determine whether brain structures are exposed to high cortisol concentrations early in AD, we measured cerebrospinal fluid (CSF) cortisol in 66 subjects with AD, 33 subjects with mild cognitive impairment (MCI) and 34 control subjects. CSF cortisol concentrations were higher in AD subjects compared to controls (p<0.001) and to MCI subjects (p=0.002). There was no significant increase of cortisol in MCI subjects compared with controls suggesting that the increase of CSF cortisol is not an early event in the course of AD.
Mots-clé
Alzheimer Disease/cerebrospinal fluid, Alzheimer Disease/diagnosis, Biological Markers/cerebrospinal fluid, Cognition Disorders/cerebrospinal fluid, Cognition Disorders/diagnosis, Humans, Hydrocortisone/cerebrospinal fluid, Neuropsychological Tests
Pubmed
Création de la notice
29/10/2012 11:41
Dernière modification de la notice
20/08/2019 16:20
Données d'usage